Project Number 5U24AG061340-05 Agency/Funding Organization NIA Funding Year 2022 View Full Project Details for AMP-AD Data Coordination Center Research Categorization Primary Disease / Condition Alzheimer's Disease CADRO Category C. Translational Research and Clinical Interventions 1. Research Resources and Enabling Technologies to Accelerate Therapy Development c. Translational Infrastructure Researcher and Organization Principal Investigator GREENWOOD, ANNA K Principal Investigator First Name ANNA K Principal Investigator Last Name GREENWOOD Awardee Organization SAGE BIONETWORKS Awardee State Washington Contact PI Country United States Project Detail Funding Opportunity Announcement RFA-AG-18-014: Limited Competition: Data Coordinating Center for the Accelerating Medicines Partnership Target Discovery and Preclinical Validation Consortium AMP-AD DCC (U24 Clinical Trial Not Allowed) FY Overall Cost $2,413,011 Funding Organization Agency/Funding Organization NIA Funding Organization Country United States Program Official PETANCESKA, SUZANA Special Initiative Accelerating Medicines Partnership - Alzheimer's Disease (AMP-AD): Target Discovery and Preclinical Validation Project
